Ironwood Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $401K | Buy |
3,171
+6
| +0.2% | +$791 | 0.05% | 198 |
|
|
2026
Q1 | $441K | Buy |
3,165
+41
| +1% | +$5.74K | 0.06% | 183 |
|
|
2025
Q4 | $384K | Buy |
3,124
+5
| +0.2% | +$608 | 0.05% | 191 |
|
|
2025
Q3 | $346K | Buy |
3,119
+68
| +2% | +$7.73K | 0.05% | 203 |
|
|
2025
Q2 | $338K | Sell |
3,051
-31
| -1% | -$3.3K | 0.05% | 200 |
|
|
2025
Q1 | $345K | Sell |
3,082
-79
| -2% | -$8.15K | 0.06% | 187 |
|
|
2024
Q4 | $292K | Buy |
3,161
+50
| +2% | +$4.5K | 0.05% | 204 |
|
|
2024
Q3 | $261K | Sell |
3,111
-2,374
| -43% | -$181K | 0.04% | 224 |
|
|
2024
Q2 | $376K | Buy |
5,485
+196
| +4% | +$13.1K | 0.07% | 187 |
|
|
2024
Q1 | $387K | Sell |
5,289
-10
| -0.2% | -$769 | 0.07% | 185 |
|
|
2023
Q4 | $429K | Sell |
5,299
-3
| -0.1% | -$233 | 0.08% | 172 |
|
|
2023
Q3 | $1.62M | Buy |
5,302
+341
| +7% | +$26.2K | 0.34% | 77 |
|
|
2023
Q2 | $382K | Sell |
4,961
-409
| -8% | -$32.6K | 0.09% | 146 |
|
|
2023
Q1 | $446K | Sell |
5,370
-402
| -7% | -$33.3K | 0.11% | 138 |
|
|
2022
Q4 | $496K | Buy |
5,772
+212
| +4% | +$16.8K | 0.12% | 126 |
|
|
2022
Q3 | $343K | Buy |
5,560
+320
| +6% | +$20.2K | 0.1% | 136 |
|
|
2022
Q2 | $323K | Buy |
5,240
+159
| +3% | +$9.84K | 0.09% | 149 |
|
|
2022
Q1 | $302K | Buy |
5,081
+150
| +3% | +$9.59K | 0.07% | 162 |
|
|
2021
Q4 | $358K | Sell |
4,931
-69
| -1% | -$4.75K | 0.08% | 148 |
|
|
2021
Q3 | $349K | Buy |
5,000
+71
| +1% | +$4.99K | 0.09% | 145 |
|
|
2021
Q2 | $339K | Buy |
4,929
+72
| +1% | +$4.81K | 0.09% | 149 |
|
|
2021
Q1 | $313K | Buy |
4,857
+760
| +19% | +$49K | 0.09% | 147 |
|
|
2020
Q4 | $238K | Sell |
4,097
-107
| -3% | -$6.46K | 0.05% | 189 |
|
|
2020
Q3 | $265K | Buy |
4,204
+361
| +9% | +$25K | 0.07% | 166 |
|
|
2020
Q2 | $295K | Sell |
3,843
-178
| -4% | -$13.6K | 0.09% | 149 |
|
|
2020
Q1 | $300K | Sell |
4,021
-106
| -3% | -$7.32K | 0.12% | 124 |
|
|
2019
Q4 | $268K | Buy |
4,127
+195
| +5% | +$12.7K | 0.09% | 148 |
|
|
2019
Q3 | $249K | Sell |
3,932
-9
| -0.2% | -$588 | 0.09% | 147 |
|
|
2019
Q2 | $266K | Buy |
3,941
+309
| +9% | +$20.3K | 0.1% | 141 |
|
|
2019
Q1 | $236K | Buy |
3,632
+81
| +2% | +$5.38K | 0.09% | 141 |
|
|
2018
Q4 | $222K | Buy |
3,551
+44
| +1% | +$3.08K | 0.1% | 138 |
|
|
2018
Q3 | $270K | Sell |
3,507
-396
| -10% | -$29.9K | 0.1% | 130 |
|
|
2018
Q2 | $276K | Buy |
+3,903
| New | +$276K | 0.12% | 119 |
|
Other funds holding GILD
Ironwood Investment Counsel's GILD Position: Q2 2026 in Review
Ironwood Investment Counsel increased its Gilead Sciences (GILD) stake by 0.19% in Q2 2026, buying an estimated $791 and bringing the position to 3,171 shares worth $401K. The position accounts for 0.05% of the portfolio, ranked #198.
Ironwood Investment Counsel first reported a position in GILD in Q2 2018 and has held it in 33 quarters since. The position peaked at $1.62M in Q3 2023. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ironwood Investment Counsel held 3,171 shares of Gilead Sciences worth $401K as of Q2 2026.
- Ironwood Investment Counsel bought 6 Gilead Sciences shares in Q2 2026, an estimated $791.
- Gilead Sciences made up 0.05% of Ironwood Investment Counsel's portfolio in Q2 2026, its #198 holding.
- Ironwood Investment Counsel first reported a position in Gilead Sciences in Q2 2018 and has held it in 33 quarters since.
- Ironwood Investment Counsel's Gilead Sciences position peaked at $1.62M in Q3 2023.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.